Home›People›Hugh McColl, III
HI

Hugh McColl, III

Director at Westrock Coffee. Also a director at Telomir Pharmaceuticals.

DirectorPublic company
Updated Nov 9, 2026·Latest SEC filing Jun 8, 2026·Suggest an edit

About Hugh McColl, III

Hugh McColl, III is a director at Westrock Coffee.

Form D filings name Hugh McColl, III as a director at Telomir Pharmaceuticals.

Hugh McColl, III reports to the SEC as a director of 3 public companies, including Telomir Pharmaceuticals (TELO) and Mira Pharmaceuticals (MIRA).

Hugh McColl, III first appears on SEC filings in 2022.

Experience

This experience comes from SEC filings. The years are when the filings name Hugh McColl, III in the role, so the role may have started earlier or lasted longer.

Westrock Coffee Co
Director
2022 – 2026 · Public company (WEST)
Telomir Pharmaceuticals, Inc.
Director
2023 – 2024 · Public company (TELO)
Mira Pharmaceuticals, Inc.
Director
2023 · Public company (MIRA)

Key Colleagues at Startups

The people Hugh McColl, III works with at each company, as listed on that company's latest Form D.

Telomir Pharmaceuticals, Inc. · Form D, Apr 3, 2023
TT
Tuck Talhia
Director
CE
Craig Eagle
Director
DV
JM
James McNulty
Treasurer, Chief Financial Officer and Secretary
CC
Chris Chapman
President, Chief Executive Officer and Chairman
JU

Sources

  1. SECTelomir Pharmaceuticals, Inc. Form D, filed Apr 3, 2023
  2. SECForms 3, 4 and 5 filed by Hugh McColl, III (SEC filer 1934476)